Effect of a Mixture of Allium Extracts on LDL Cholesterol Levels Volunteers With Elevated LDL Cholesterol Levels
NCT ID: NCT04646382
Last Updated: 2023-02-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
64 participants
INTERVENTIONAL
2021-02-01
2022-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of a Black Garlic Extract on Cholesterol LDL Levels
NCT04010565
Hypocholesterolemic Effect of Fibracep
NCT04545463
Study of Lipid Control in Hyperlipidemic Participants (MK-0653-179)
NCT01436253
Trial to Evaluate Safety and Tolerability of ALN-PCS02 in Subjects With Elevated LDL-Cholesterol (LDL-C)
NCT01437059
LDL-cholesterol Lowering Effect of a New Dietary Supplement
NCT03425630
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
64 healthy volunteers lwith elevated LDL cholesterol levels but who do not require pharmacological treatment will be randomly distributed into 2 equal groups: control group and intervention group.
For 8 weeks the volunteers will take the product immediately after lunch. During that time they will maintain their lifestyle and nutritional habits.
Blood samples will be taken at 0, 2, 4 and 8 weeks. Anthropometric parameters and health-related data were also measured.
Parameters related to lipid metabolism, metabolic syndrome and the immune system will be analized.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
The "pot number" is the same as the "participant number".
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
Microcrystalline cellulose (9892- Capsules®) up to 400 mg.
Garlic and onion concentrate
Garlic extract concentrate (equivalent to 2 garlic cloves) and onion extract concentrate (equivalent to 1 onion).
Control
Microcrystalline cellulose
Intervention
Garlic concentrated extract. Onion concentrated extract. Microcrystalline cellulose (9892- Capsules®) up to 400 mg.
Garlic and onion concentrate
Garlic extract concentrate (equivalent to 2 garlic cloves) and onion extract concentrate (equivalent to 1 onion).
Control
Microcrystalline cellulose
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Garlic and onion concentrate
Garlic extract concentrate (equivalent to 2 garlic cloves) and onion extract concentrate (equivalent to 1 onion).
Control
Microcrystalline cellulose
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Freely agree to participate in the study and sign the informed consent document.
Exclusion Criteria
* Have planned to change lifestyle and / or dietary habits.
* Having diabetes.
* Having a cerebrovascular disease.
* Having a serious illness.
* Taking products or drugs to control cholesterol levels or with antioxidant activity.
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
DOMCA S.A.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Miguel Quesada, MD
Role: PRINCIPAL_INVESTIGATOR
Endocrinology and Nutrition Clinic of Dr. Miguel Quesada
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Domca Sau
Alhendín, Granada, Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
C003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.